Tetsuo Touyama

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study

Eiji Oki, Takeshi Kato, Hideaki Bando et al. · Clinical Colorectal Cancer · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +12

Partial Breast Reconstruction for an Inferomedial Breast Carcinoma Using an Omental Flap

Hisamitsu Zaha, Hiroki Sunagawa, Kouji Kawakami et al. · World Journal of Surgery · 2010 · 40 citations

Medicine, Plastic Surgery, Surgery +16

Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)

Masahito Kotaka, Takayuki Yoshino, Koji Oba et al. · Cancer Chemotherapy and Pharmacology · 2015 · 28 citations · Full text

Pharmacy, Oncology, Chemotherapy +16

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer

Takayuki Yoshino, Masahito Kotaka, Katsunori Shinozaki et al. · Cancer Chemotherapy and Pharmacology · 2019 · 27 citations · Full text

Medicine, Oncology, Chemotherapy +13

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

Yoshinori Munemoto, Masato Nakamura, Masazumi Takahashi et al. · European Journal of Cancer · 2019 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16